Warning This website requires JavaScript to function correctly. Please enable JavaScript in your web browser settings or white-list our domain "www.bbisolutions.com" if you use any plug-ins to block JavaScript.

Our History

BBI Solutions history timeline

BBI was founded in 1986, when John Chandler at Cardiff University developed and manufactured our now world-renowned gold nanoparticles for the first time and supplied them to the electron microscopy industry.

Since then, the company has grown its portfolio of products to include gold reagents, antibodies, antigens, enzymes, serum and plasma, cell culture reagents as well as offering antibody development services,
lateral flow assay development and manufacture, and of course, our Novarum™ smartphone diagnostic platform.

See how we have grown

1986

The BBI Group was established in 1986 with only 10 staff…

And had a turnover of less than £1 Million.

2000

BBI achieved an MBO.

2004

BBI achieved an IPO.

2006

Growth continues through the product and service, acquisitions and new entities.

2008

The BBI Group was sold to Alere for £85m. Alere are a global POC leader.

2013

We rebranded to bring our complete offering together as BBI Solutions.

2015

The BBI Group became an independent company following an the acquisition by Exponent Private Equity.

2016

BBI Solutions acquired Novarum DX Ltd.

2018

Invested £14m in the new BBI Group Global Headquarters.

2020

April 2020, BBI Group joins the UK Rapid Test Consortium to rapidly develop and rollout the Coronavirus tests.

June 2020, BBI Group acquires DIARECT AG, establishing BBI as the leading provider of antigens in the autoimmune and tick-borne IVD markets

2021

Aquisition of BBI group by Novo Holdings

2022

January 2022 aquisition of Biotez GmbH and Steffens Biotechnische Analysen GmbH

BBI Solutions Brands

DIARECT has a world leading recombinant autoimmune antigen capability immediately that enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier.

Maine Biotechnology Services brings 28 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application.

Novarum™ technology transforms a smartphone into a diagnostic test reader and work flow management system , empowering users to read and share the results of rapid tests at the point of care connecting patients and doctors, field workers, lab researchers and primary care clinicians to specialist practices as part of a mobile eco-system.

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox